RCEL (Avita Medical, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Avita Medical, Inc. Common Stock (RCEL) is a publicly traded Healthcare sector company. As of May 21, 2026, RCEL trades at $4.32 with a market cap of $128.95M and a P/E ratio of -2.74. RCEL moved +3.22% today. Year to date, RCEL is +24.50%; over the trailing twelve months it is -35.52%. Its 52-week range spans $3.22 to $14.16. Analyst consensus is strong buy with an average price target of $7.17. Rallies surfaces RCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns RCEL stock?
Hedge funds tracked by Rallies that own RCEL include Orbimed Advisors and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avita Medical, Inc. Common Stock.
RCEL Key Metrics
Key financial metrics for RCEL
Metric
Value
Price
$4.32
Market Cap
$128.95M
P/E Ratio
-2.74
EPS
$-1.56
Dividend Yield
0.00%
52-Week High
$14.16
52-Week Low
$3.22
Volume
0
Avg Volume
0
Revenue (TTM)
$72.35M
Net Income
$-45.34M
Gross Margin
81.36%
Top Hedge Funds Holding RCEL
Orbimed Advisors holds 544.89K shares of RCEL, changed +0.00% as of Mar 31, 2026.
Centerbook Partners holds 145.35K shares of RCEL, changed +751.08% as of Mar 31, 2024.
Hedge funds tracked by Rallies that own RCEL include Orbimed Advisors and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avita Medical, Inc. Common Stock.
Does Rallies show 13F holders for RCEL?
Yes. Rallies tracks hedge fund and 13F ownership data for RCEL, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RCEL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RCEL. It does not provide personalized investment advice.
